181 related articles for article (PubMed ID: 21249361)
1. The hypofunctional effect of P335L single nucleotide polymorphism on SSTR5 function.
Zhou G; Gingras MC; Liu SH; Li D; Li Z; Catania RL; Stehling KM; Li M; Paganelli G; Gibbs RA; Demayo FJ; Fisher WE; Brunicardi FC
World J Surg; 2011 Aug; 35(8):1715-24. PubMed ID: 21249361
[TBL] [Abstract][Full Text] [Related]
2. SSTR5 P335L monoclonal antibody differentiates pancreatic neuroendocrine neuroplasms with different SSTR5 genotypes.
Zhou G; Gingras MC; Liu SH; Sanchez R; Edwards D; Dawson D; Christensen K; Paganelli G; Gibbs R; Fisher W; Brunicardi FC
Surgery; 2011 Dec; 150(6):1136-42. PubMed ID: 22136833
[TBL] [Abstract][Full Text] [Related]
3. Negative regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5.
Zhou G; Liu SH; Shahi KM; Wang H; Duan X; Lin X; Feng XH; Li M; Fisher WE; Demayo FJ; Dawson D; Brunicardi FC
Mol Endocrinol; 2012 Jul; 26(7):1225-34. PubMed ID: 22669743
[TBL] [Abstract][Full Text] [Related]
4. Association between somatostatin receptor 5 gene polymorphisms and pancreatic cancer risk and survival.
Li D; Tanaka M; Brunicardi FC; Fisher WE; Gibbs RA; Gingras MC
Cancer; 2011 Jul; 117(13):2863-72. PubMed ID: 21692047
[TBL] [Abstract][Full Text] [Related]
5. Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide.
Fisher WE; Muscarella P; O'Dorisio TM; O'Dorisio MS; Kim JA; Doran TA; Sabourin CL; Schirmer WJ
Surgery; 1996 Aug; 120(2):234-40; discussion 240-1. PubMed ID: 8751588
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic somatostatin inhibits insulin secretion via SSTR-5 in the isolated perfused mouse pancreas model.
Tirone TA; Norman MA; Moldovan S; DeMayo FJ; Wang XP; Brunicardi FC
Pancreas; 2003 Apr; 26(3):e67-73. PubMed ID: 12657967
[TBL] [Abstract][Full Text] [Related]
7. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
8. Specific gene expression and therapy for pancreatic cancer using the cytosine deaminase gene directed by the rat insulin promoter.
Wang XP; Yazawa K; Yang J; Kohn D; Fisher WE; Brunicardi FC
J Gastrointest Surg; 2004 Jan; 8(1):98-108; discussion 106-8. PubMed ID: 14746841
[TBL] [Abstract][Full Text] [Related]
9. Double-gene ablation of SSTR1 and SSTR5 results in hyperinsulinemia and improved glucose tolerance in mice.
Wang XP; Norman MA; Yang J; Cheung A; Moldovan S; Demayo FJ; Brunicardi FC
Surgery; 2004 Sep; 136(3):585-92. PubMed ID: 15349106
[TBL] [Abstract][Full Text] [Related]
10. KAI1 inhibits lymphangiogenesis and lymphatic metastasis of pancreatic cancer in vivo.
Liu X; Guo XZ; Li HY; Chen J; Ren LN; Wu CY
Hepatobiliary Pancreat Dis Int; 2014 Feb; 13(1):87-92. PubMed ID: 24463085
[TBL] [Abstract][Full Text] [Related]
11. Microarray analysis of somatostatin receptor 5-regulated gene expression profiles in murine pancreas.
Patel SG; Zhou G; Liu SH; Li M; Jeong JW; DeMayo FJ; Gingras MC; Gibbs RA; Fisher WE; Brunicardi FC
World J Surg; 2009 Apr; 33(4):630-7. PubMed ID: 19137362
[TBL] [Abstract][Full Text] [Related]
12. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis.
Lou Y; Li R; Xiong L; Gu A; Shi C; Chu T; Zhang X; Gu P; Zhong H; Wen S; Han B
Tumour Biol; 2013 Dec; 34(6):3967-79. PubMed ID: 23852860
[TBL] [Abstract][Full Text] [Related]
13. [MiR-150-5p inhibits the proliferation and promoted apoptosis of pancreatic cancer cells].
Sun Y; Jin XL; Zhang TT; Jia CW; Chen J
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):460-4. PubMed ID: 24246865
[TBL] [Abstract][Full Text] [Related]
14. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
Weckbecker G; Raulf F; Bodmer D; Bruns C
Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
[TBL] [Abstract][Full Text] [Related]
15. Increased tumorigenicity in the human pancreatic cell line MIA PaCa-2 is associated with an aberrant regulation of an IGF-1 autocrine loop and lack of expression of the TGF-beta type RII receptor.
Freeman JW; Mattingly CA; Strodel WE
J Cell Physiol; 1995 Oct; 165(1):155-63. PubMed ID: 7559796
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD44, CD24 and ESA in pancreatic adenocarcinoma cell lines varies with local microenvironment.
Wei HJ; Yin T; Zhu Z; Shi PF; Tian Y; Wang CY
Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):428-34. PubMed ID: 21813394
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5: a novel mechanism for inhibition of cellular proliferation and insulin secretion by somatostatin.
Zhou G; Sinnett-Smith J; Liu SH; Yu J; Wu J; Sanchez R; Pandol SJ; Abrol R; Nemunaitis J; Rozengurt E; Brunicardi FC
Front Physiol; 2014; 5():226. PubMed ID: 25009500
[TBL] [Abstract][Full Text] [Related]
18. The effect of global SSTR5 gene ablation on the endocrine pancreas and glucose regulation in aging mice.
Wang XP; Norman M; Yang J; Liu SH; Magnusson J; DeMayo FJ; Brunicardi FC
J Surg Res; 2005 Nov; 129(1):64-72. PubMed ID: 16026801
[TBL] [Abstract][Full Text] [Related]
19. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
Bi YL; Min M; Shen W; Liu Y
Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
[TBL] [Abstract][Full Text] [Related]
20. Characterization of somatostatin receptor expression in human pancreatic cancer using real-time RT-PCR.
Li M; Li W; Kim HJ; Yao Q; Chen C; Fisher WE
J Surg Res; 2004 Jun; 119(2):130-7. PubMed ID: 15145694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
